Singapore legislation
Regulation 19
Regulation 19
Definitions for this Part
In this Part —“CEC licensee” means a licensee who is required to appoint a clinical ethics committee under regulation 23C;“clinical appropriateness”, in relation to a licensable healthcare service provided by a QAC licensee to a patient, means the appropriateness of the clinical care that is provided to the patient, as determined by —
the extent to which the relevant clinical care plans and clinical procedures are properly executed by the QAC licensee in relation to the patient; and
whether there is evidence that those clinical procedures are beneficial to the patient; “clinical ethics committee” or “CEC” means a clinical ethics committee appointed pursuant to regulation 23C;“mortality and morbidity review” or “MMR” means a review of the circumstances surrounding either of the following:
the death of a patient, except where the event that caused the patient’s death is a serious reportable event;
any clinical incident with other adverse consequences, but is not death or a serious reportable event;“peer review learning” or “PRL” means the encouragement of learning and improvement of quality of care through a documented review and evaluation of a specialist’s competencies and performance by one or more other specialists in the same branch of medicine, including identifying the areas for improvement;“prescribed programme or activity” means any programme or activity set out in Part 2 of the Third Schedule;“QAC licensee” means a licensee who belongs to any of the categories of licensees specified in the first column of Part 1 of the Third Schedule that is required to appoint a quality assurance committee;“quality assurance committee” or “QAC” means a quality assurance committee appointed pursuant to regulation 20;“referring licensee”, in relation to a CEC, means a licensee who is not a section 25 licensee and who refers or causes to be referred any proposed prescribed medical treatment to the CEC for an ethics review under section 26(2)(b) of the Act;“serious reportable event” means an adverse event occurring, or that has occurred, during the care or treatment of a patient that —
has caused, or is likely to cause, death, serious injury or other harm to the patient; and (b)is not an intended or expected outcome of any examination, procedure or treatment provided to the patient;“service review committee” or “SRC” means a service review committee appointed pursuant to regulation 23A;“specialist” means a person who is registered as a specialist in the Register of Specialists under section 22 of the Medical Registration Act 1997 or section 14C of the Dental Registration Act 1999;“SRC licensee” means a licensee who is required to appoint a service review committee under regulation 23A.
Definition
“CEC licensee” means a licensee who is required to appoint a clinical ethics committee under regulation 23C;
Definition
“clinical appropriateness”, in relation to a licensable healthcare service provided by a QAC licensee to a patient, means the appropriateness of the clinical care that is provided to the patient, as determined by —
the extent to which the relevant clinical care plans and clinical procedures are properly executed by the QAC licensee in relation to the patient; and
whether there is evidence that those clinical procedures are beneficial to the patient;
Definition
“clinical ethics committee” or “CEC” means a clinical ethics committee appointed pursuant to regulation 23C;
Definition
“mortality and morbidity review” or “MMR” means a review of the circumstances surrounding either of the following:
the death of a patient, except where the event that caused the patient’s death is a serious reportable event;
any clinical incident with other adverse consequences, but is not death or a serious reportable event;
Definition
“peer review learning” or “PRL” means the encouragement of learning and improvement of quality of care through a documented review and evaluation of a specialist’s competencies and performance by one or more other specialists in the same branch of medicine, including identifying the areas for improvement;
Definition
“prescribed programme or activity” means any programme or activity set out in Part 2 of the Third Schedule;
Definition
“QAC licensee” means a licensee who belongs to any of the categories of licensees specified in the first column of Part 1 of the Third Schedule that is required to appoint a quality assurance committee;
Definition
“quality assurance committee” or “QAC” means a quality assurance committee appointed pursuant to regulation 20;
Definition
“referring licensee”, in relation to a CEC, means a licensee who is not a section 25 licensee and who refers or causes to be referred any proposed prescribed medical treatment to the CEC for an ethics review under section 26(2)(b) of the Act;
Definition
“serious reportable event” means an adverse event occurring, or that has occurred, during the care or treatment of a patient that —
has caused, or is likely to cause, death, serious injury or other harm to the patient; and (b)is not an intended or expected outcome of any examination, procedure or treatment provided to the patient;
Definition
“service review committee” or “SRC” means a service review committee appointed pursuant to regulation 23A;
Definition
“specialist” means a person who is registered as a specialist in the Register of Specialists under section 22 of the Medical Registration Act 1997 or section 14C of the Dental Registration Act 1999;
Definition
“SRC licensee” means a licensee who is required to appoint a service review committee under regulation 23A.